SINOCARE AND NIPRO COMPLETED AND SETTLED ON THE ACQUISITION OF NIPRO DIAGNOSTICS INC.

  Sinocare

  On January 8, 2016 in Changsha, China, Sinocare Inc. (300298:Shenzhen) announced the acquisition of Nipro Diagnostics Co., Ltd. as a whole and officially changed the name to Trividia Health, Inc. Mr. Scott Verner was appointed CEO and President of Trividia Health, Inc. whose core management staff in the original team will join the management of the new company. The company will continue to carry out related business in the United States.

      On January 8, 2016 in Changsha, China, Sinocare Inc. (300298:Shenzhen) announced the acquisition of Nipro Diagnostics Co., Ltd. as a whole and officially changed the name to Trividia Health, Inc. Mr. Scott Verner was appointed CEO and President of Trividia Health, Inc. whose core management staff in the original team will join the management of the new company. The company will continue to carry out related business in the United States.

      “Like Sinocare, Trividia Health, Inc. also has a long-term vision to become a global leader in health and wellness, and is committed to providing patients with innovative, high-quality solutions that enable them to live healthier lives,” said Mr. Li Shaobo, the Chairman and CEO of Sinocare. “We have a great deal of respect for what the management team and staff have accomplished in Trividia Health, Inc. (formerly Nipro Diagnostics, Inc.) and we are confident in their ability to realize our shared vision. The joint efforts in designing mature products and services, sharing vision on the future development and holding confidence in designers, production and sales staff are critical to achieving our common goals.”

      “The company is in a strong-growth trend due to the pace of our new product launches and our investment in cutting-edge manufacturing and distribution facilities in the United States, which is an exciting new chapter for the merged company. I look forward to furthering our potential expansion in the global market and providing a portfolio of holistic solutions for patients, healthcare providers and our clients,” said Mr. Scott Verner.

      The new company name Trividia Health marks the company’s new trajectory, representing the values, vision and market of this global company. The word “Trividia” can be divided into: “Tri” indicates the three promises Sinocare made to its customers, employees and shareholders; “Vi” means the commitment to help patients defeat diabetes and other health challenges; and “Dia” refers to diabetes, the core foundation business of the company. The word “health” represents that the company’s new business focuses on developing other holistic health solutions beyond diabetes.

       About Trividia Health Inc.

Trividia Health Inc., a subsidiary of Sinocare, is a global health and wellness company located in Fort Lauderdale, Florida, USA. It is a leading developer, producer and promoter of high-performance products for people with diabetes. The company, with a portfolio of TRUE brand products, is the exclusive partner and supplier for leading global retail pharmacies, resellers and mail-order service providers of cost-effective, high-quality blood glucose monitoring systems and health and wellness solutions. For more information, please visit the company’s official website: www.TrividiaHealth.com.

       About Sinocare

Sinocare consists of Sinocare, Inc., Trividia Health, Inc., Sinocare Hengtang Diabetes Hospital and its affiliates. Headquartered in Changsha, China, Sinocare is committed to promote the popularization of blood glucose meter in China through the use of innovative bio-sensing technologies and to provide comprehensive diabetes services and solutions. The company has been providing Chinese diabetic patients with cost-effective blood glucose monitoring products. The company was established in 2002 and listed on the Shenzhen Stock Exchange (300298:Shenzhen) in 2012. It was listed in the “Forbes Asia’s Best Under A Billion (BUB) list 2015”.


RECENT POSTS
XML 地图 | Sitemap 地图